80 results on '"Zerbetto, F"'
Search Results
2. PO-1129 Stereotactic re-irradiation of relapsed intracranic lesions: a monoinstitutional experience
3. PO-1248 Outcomes of hypofractionated locoregional radiotherapy in advanced breast cancer
4. PO-1111 Robotic stereotactic radiotherapy for ≥ 10 brain metastases treated with single treatment planning.
5. PO-1355 Impact of lymphopenia in patients with esophageal cancer after neoadjuvant chemoradiotherapy
6. PO-1232 The impact of weight loss in head and neck cancer patients treated with chemo-radiotherapy
7. PD-0914 SBRT versus ENRT in oligometastatic gynaecologic tumors: techniques comparison.
8. MO-0553 ENRT+ PET-guided SIB for prostate cancer lymph nodal relapses: long-term outcomes
9. PO-1100 Impact of sarcopenia in oropharyngeal cancer patients treated with radical chemo-radiotherapy
10. MO-0717 Radiation Therapy and Cardiovascular Implanted Electronic Devices: a single center years expierence
11. PD-0085 SBRT in the management of oligometastatic gynaecological cancer: a mono-institutional experience.
12. PO-1177 Acute toxicity of hypofractionated locoregional radiotherapy in advanced breast cancer
13. PO-1069 Multiple Brain Metastases concomitantly treated with robotic SRS/SRT
14. PO-1307 Extended nodal radiotherapy for relapsed gynecologic tumors with PET/CT-guided SIB
15. PO-1401 Lung metastasis from renal cell carcinoma: SBRT alone or in association with target therapy as a potential treatment option
16. PO-1025 Outcomes of re-irradiation of relapsed intracranic lesions with stereotactic radiotherapy
17. PO-1131 Primary tumors observed in 1325 consecutive breast cancer patients treated with whole breast RT
18. PO-1300 Stereotactic Body Radiation Therapy for oligometastatic lymph-nodal relapses in gynecological cancer
19. PO-1354 Time Dependence of PSADT prognostic threshold in men treated with post-prostatectomy salvage RT
20. PO-1308 Image-guided helical/volumetric IMRT in vulvar cancer: results of a mono-institutional experience
21. PO-1139 Skin toxicity in 1325 breast cancer patients treated with hypofractionated RT without boost
22. PO-1266: Radical radiotherapy in elderly prostate cancer patients: a monoinstitutional experience.
23. PO-0955: Molecular subtypes and local control in 1054 breast cancer patients treated with de-escalated 3DCRT
24. PO-0879: Stereotactic radiotherapy for re-irradiation of relapsed intracranic lesions
25. PO-1246: Stereotactic Body Radiotherapy For Bone Metastases In Oligometastatic-Oligoprogressive Patients
26. PO-1173: Long term results of IG-IMRT in high risk prostate cancer patients: a monoinstitutional experience
27. PO-1603: Residual intra-fraction error in tracked spinal SBRT: effect of site, fractionation and patient pain
28. EP-1553 High-dose hypofractionated helical IG-IMRT in high-risk prostate cancer patients
29. EP-1303 Hypofractionated adjuvant radiotherapy in elderly low risk breast cancer patients: loss or gain?
30. EP-1993 Evidence of CTV underdosing due to anatomical changes during breast Helical Tomotherapy
31. EP-1640 Radical radiotherapy in elderly prostate cancer patients: a monoinstitutional experience
32. EP-1191: Outcomes of a mono-institutional experience of IG-IMRT in Glioblastoma
33. EP-1221: Hypoxia imaging with 18F-FAZA PET/CT in Radiotherapy Planning for High Grade Gliomas
34. PO-0694: Post-operative Intensity-Modulated hypofractionated Image-Guided Radiotherapy in cholangiocarcinoma
35. EP-1159: Hypofractionated adjuvant radiotherapy and concomitant trastuzumab for breast cancer: 5-year results
36. PO-0651: Five year outcome and soft tissue toxicity of breast cancer hypofractionated adjuvant radiotherapy
37. EP-1079: Clinical outcomes in locally advanced oropharyngeal cancer 18FDG PET-guided dose escalation IMRT-SIB
38. FDG-PET positive lymph node variations during image-guided IMRT for head and neck cancer identify non-responding patients
39. PO-1087 Gastrointestinal toxicity in post-prostatectomy pelvis irradiation: intestinal loops and sigmoid colon contouring
40. EP-1878: Haematology toxicity evaluation in whole pelvis RT: Implementing a procedure for contouring bone marrow structures
41. EP-1281: Predicting prospectively patient-reported acute bowel symptoms in post prostatectomy IMRT including pelvic nodes
42. PO-0729: Haematologic toxicity from post-prostatectomy whole pelvis RT is not negligible and prolonged. A prospective study
43. PO-0899: Lymphnodes shrinkage measured during RT by daily MVCT predicts tumour relapses of head-and-neck cancer
44. PD-0306: Factors influencing urinary incontinence following post-prostatectomy IMRT irradiation. A prospective study
45. OC-0141: Modeling severe late GU toxicity after post-prostatectomy RT with the LQ-model: evidence of a consequential effect
46. 183 Pelvic lymph-nodal irradiation improves biochemical relapse-free survival of node-negative patients treated with high-dose salvage radiotherapy after radical prostatectomy. A single-institute analysis of 206 patients
47. 184 Factors predicting severe (Grade 3–4) late urinary toxicity after post-prostatectomy irradiation. A single institution analysis of 1151 patients treated with adjuvant or salvage radiotherapy with different radiation techniques and fractionations
48. OC-0053: Factors predicting Grade 3-4 late urinary toxicity in 1176 patients treated with post-prostatectomy irradiation
49. 185 Reliability and ideal cut-off of PSA doubling time in patients candidate to timely salvage radiotherapy for a biochemical recurrence after prostatectomy
50. PO-0728: Longitudinal evaluation of acute haematologic toxicity from wholepelvis post-prostatectomy radiotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.